Array BioPharma Inc-Product Pipeline Review-2015

Array BioPharma Inc-Product Pipeline Review-2015


  • Products Id :- GMDHC07697CDB
  • |
  • Pages: 68
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Array BioPharma Inc-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'Array BioPharma Inc-Product Pipeline Review-2015', provides an overview of the Array BioPharma Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Array BioPharma Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Array BioPharma Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Array BioPharma Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Array BioPharma Inc.'s pipeline products

Reasons To Buy

Evaluate Array BioPharma Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Array BioPharma Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Array BioPharma Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Array BioPharma Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Array BioPharma Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Array BioPharma Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Array BioPharma Inc. Snapshot 6

Array BioPharma Inc. Overview 6

Key Information 6

Key Facts 6

Array BioPharma Inc-Research and Development Overview 7

Key Therapeutic Areas 7

Array BioPharma Inc-Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products-Monotherapy 11

Pipeline Products-Combination Treatment Modalities 12

Pipeline Products-Partnered Products 13

Partnered Products/Combination Treatment Modalities 14

Pipeline Products-Out-Licensed Products 15

Out-Licensed Products/Combination Treatment Modalities 16

Array BioPharma Inc-Pipeline Products Glance 17

Array BioPharma Inc-Late Stage Pipeline Products 17

Phase III Products/Combination Treatment Modalities 17

Array BioPharma Inc-Clinical Stage Pipeline Products 18

Phase II Products/Combination Treatment Modalities 18

Phase I Products/Combination Treatment Modalities 19

Array BioPharma Inc-Early Stage Pipeline Products 20

Preclinical Products/Combination Treatment Modalities 20

Discovery Products/Combination Treatment Modalities 21

Array BioPharma Inc-Unknown Stage Pipeline Products 22

Unknown Products/Combination Treatment Modalities 22

Array BioPharma Inc-Drug Profiles 23

binimetinib 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

binimetinib + encorafenib 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

encorafenib 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

filanesib 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

ARRY-502 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

ARRY-797 35

Product Description 35

Mechanism of Action 35

R&D Progress 35

pexmetinib 37

Product Description 37

Mechanism of Action 37

R&D Progress 37

AR-460770 38

Product Description 38

Mechanism of Action 38

R&D Progress 38

AR-523 39

Product Description 39

Mechanism of Action 39

R&D Progress 39

AR-786 40

Product Description 40

Mechanism of Action 40

R&D Progress 40

ARRY-981 41

Product Description 41

Mechanism of Action 41

R&D Progress 41

Small Molecules for Inflammation 42

Product Description 42

Mechanism of Action 42

R&D Progress 42

AR-00457679 43

Product Description 43

Mechanism of Action 43

R&D Progress 43

ARRY-111 44

Product Description 44

Mechanism of Action 44

R&D Progress 44

Small Molecules to Inhibit Kinase for Autoimmune Disorders 45

Product Description 45

Mechanism of Action 45

R&D Progress 45

Array BioPharma Inc-Pipeline Analysis 46

Array BioPharma Inc-Pipeline Products by Target 46

Array BioPharma Inc-Pipeline Products by Route of Administration 48

Array BioPharma Inc-Pipeline Products by Molecule Type 49

Array BioPharma Inc-Pipeline Products by Mechanism of Action 50

Array BioPharma Inc-Recent Pipeline Updates 52

Array BioPharma Inc-Dormant Projects 62

Array BioPharma Inc-Dormant Projects 62

Array BioPharma Inc-Discontinued Pipeline Products 63

Discontinued Pipeline Product Profiles 63

ARRY-797 63

Array BioPharma Inc-Company Statement 64

Array BioPharma Inc-Locations And Subsidiaries 66

Head Office 66

Other Locations & Subsidiaries 66

Appendix 67

Methodology 67

Coverage 67

Secondary Research 67

Primary Research 67

Expert Panel Validation 67

Contact Us 67

Disclaimer 68

List of Tables

Array BioPharma Inc., Key Information 6

Array BioPharma Inc., Key Facts 6

Array BioPharma Inc-Pipeline by Indication, 2015 8

Array BioPharma Inc-Pipeline by Stage of Development, 2015 10

Array BioPharma Inc-Monotherapy Products in Pipeline, 2015 11

Array BioPharma Inc-Combination Treatment Modalities in Pipeline, 2015 12

Array BioPharma Inc-Partnered Products in Pipeline, 2015 13

Array BioPharma Inc-Partnered Products/ Combination Treatment Modalities, 2015 14

Array BioPharma Inc-Out-Licensed Products in Pipeline, 2015 15

Array BioPharma Inc-Out-Licensed Products/ Combination Treatment Modalities, 2015 16

Array BioPharma Inc-Phase III, 2015 17

Array BioPharma Inc-Phase II, 2015 18

Array BioPharma Inc-Phase I, 2015 19

Array BioPharma Inc-Preclinical, 2015 20

Array BioPharma Inc-Discovery, 2015 21

Array BioPharma Inc-Unknown, 2015 22

Array BioPharma Inc-Pipeline by Target, 2015 46

Array BioPharma Inc-Pipeline by Route of Administration, 2015 48

Array BioPharma Inc-Pipeline by Molecule Type, 2015 49

Array BioPharma Inc-Pipeline Products by Mechanism of Action, 2015 50

Array BioPharma Inc-Recent Pipeline Updates, 2015 52

Array BioPharma Inc-Dormant Developmental Projects,2015 62

Array BioPharma Inc-Discontinued Pipeline Products, 2015 63

Array BioPharma Inc., Other Locations 66

List of Figures

Array BioPharma Inc-Pipeline by Top 10 Indication, 2015 8

Array BioPharma Inc-Pipeline by Stage of Development, 2015 10

Array BioPharma Inc-Monotherapy Products in Pipeline, 2015 11

Array BioPharma Inc-Combination Treatment Modalities in Pipeline, 2015 12

Array BioPharma Inc-Partnered Products in Pipeline, 2015 13

Array BioPharma Inc-Out-Licensed Products in Pipeline, 2015 15

Array BioPharma Inc-Pipeline by Top 10 Target, 2015 46

Array BioPharma Inc-Pipeline by Top 10 Route of Administration, 2015 48

Array BioPharma Inc-Pipeline by Top 10 Molecule Type, 2015 49

Array BioPharma Inc-Pipeline Products by Top 10 Mechanism of Action, 2015 50

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Array BioPharma Inc.; Array BioPharma Inc-Key Therapeutics; Array BioPharma Inc-Pipeline Overview and Promising Molecules; Array BioPharma Inc-News; Array BioPharma Inc-Latest Updates; Array BioPharma Inc-Pipeline; Array BioPharma Inc-Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 97410
Site License
USD 3000 INR 194820
Corporate User License
USD 4500 INR 292230

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com